Current Opinion in Hematology was launched in 1994. It is part of a successful series of review journals whose unique format is designed to provide a systematic and critical assessment of the literature as presented in the many primary journals. The field of hematology is divided into nine sections that are reviewed once a year. Each section is assigned a Section Editor, a leading authority in the area, who identifies the most important topics at that time. Here we are pleased to introduce the Section Editors for this issue.
Dr Narla Mohandas is Vice President for Research at New York Blood Center, New York, USA. He received his doctoral degree from Washington University, St. Louis, USA in Chemical Engineering. After completing post-doctoral training in hematology research with Dr Marcel Bessis, Institute of Cellular Pathology in Paris, France, he joined the Faculty of Laboratory Medicine at University of California, San Francisco where he spent 13 years. In 1989, he moved to Lawrence Berkeley National Laboratory, University of California to head the Hematopoiesis group. During his 12-year tenure at the Berkeley Laboratory he also served as Interim Director of Human Genome Project for three years. In 2001, he moved to the New York Blood Center.
Dr Mohandas’ scientific interests during his 45-year research career have focused on red cell physiology and pathology. In particular, his efforts have contributed to improved understanding of the molecular and structural basis for red cell membrane disorders, developing detailed mechanistic insights into pathophysiology of thalassemias and sickle cell disease, characterizing structural and functional changes induced in red cells by the malarial parasite, plasmodium falciparum. His research efforts during last ten years are focused on molecular understanding of normal and disordered human erythropoiesis including Diamond-Blackfan anemia and Myelodysplasia.
Dr Mohandas served as a member of the National Institutes of Health Hematology study section for 18 years and is currently member of the NHLBI Advisory Council. He has been a member of numerous committees including the Executive committee of American Society of Hematology. He served as Associate Editor of Blood from 2003–2012 and is currently Editor-in-Chief of Blood Cells, Molecules and Disease and of Current Opinion in Hematology.
Dr Sandrina Kinet received her PhD in Biology from the University of Liège, Belgium. After completing two post-doctoral training programs in the fields of Evolutionary Biology and Immunology in France, she was recruited as a tenured CNRS staff scientist at the Institut de Génétique Moléculaire in Montpellier, France. Her initial research efforts focused on evaluating the importance of the metabolism in the functionality of human hematopoietic cells. Her major interest rapidly evolved into the study of how nutrient availability and utilization regulate hematopoietic stem cell (HSC) differentiation towards the erythroid lineage. This work has contributed to our understanding of the impact of metabolic modulation during erythroid cell differentiation. Her long-term goal is to dissect the mechanisms via which specific metabolites modulate both physiological and pathological erythropoiesis. Additionally, over the past few years, she has invested a significant effort in promoting the “transmission” of scientific knowledge to the community, teaching graduate students at the University of Montpellier and promoting the success of women in science through graduate student and community initiatives.
M. Luisa Iruela-Arispe
Dr M. Luisa Iruela-Arispe is currently professor and chair of the Department of Cell and Developmental Biology at Northwestern University – Feinberg School of Medicine. Her research centers in understanding the molecular regulation of endothelial cell commitment and differentiation, patterning and homeostatic regulation of the vasculature. She has published nearly 200 research peer review articles. A major component of this work has centered on the multiple effects of VEGF and Notch signaling in blood vessels, including their key contributions to diseases such as Alagille syndrome and CADASIL. In addition, her efforts have expanded current understanding of the mechanisms associated with vascular regeneration and the impact of mechanobiology on vascular function.
In addition to her scientific impact, Dr Iruela-Arispe is strongly committed to education and broadening the diversity of the work force in biomedical research. Along these lines, she has served on committees for several societies and organizations (including AHA, AACR, and NAVBO) in different capacities including as president (NAVBO 2007), but in all cases with the firm goal to improve representation of women and minorities in the sciences. As Director of the Molecular Biology Institute and Chair of the Biomedical Graduate Program at UCLA (1998–2019), she spearheaded initiatives, actions, and events directed at improving cultures of inclusive excellence at the level of faculty and graduate students. Since 1994, she has mentored 20 graduate students and 23 postdoctoral fellows, all of whom are currently employed in academia or in industry. In 2002 she created a graduate training program in Vascular Biology that has been supported continuously by an NIH T32 award and is now in its fourth iteration. In 2009, she was recognized with the Distinguished Teaching Award for excellence in teaching and received the post-doctoral mentor award, given to one mentor at UCLA by the post-doctoral society. Currently she is a member of the NHLBI Advisory Council, Professor and Chair at Northwestern University. Her goal is to continue to expand and foster the growth of a vibrant, diverse, and inclusive group of faculty and trainees to address fundamental questions with impact to human health.